BMJ  2005;331:1364 (10 December), doi:10.1136/bmj.38645.660093.68 (published 10 November 2005)

Paper

Achieving the millennium development goals for health

Cost effectiveness analysis of strategies for tuberculosis control in developing countries

This article is part of a series examining the cost effectiveness of strategies to achieve the millennium development goals for health

¹ Institute for Medical Technology Assessment (iMTA), Erasmus Medical Centre, PO Box 1738, 3000 DR Rotterdam, Netherlands, ² Stop TB Department, World Health Organization, Geneva, Switzerland, ³ Stop TB Department, World Health Organization, Geneva, Switzerland

Objective To assess the costs and health effects of tuberculosis control interventions in Africa and South East Asia in the context of the millennium development goals.

Design Cost effectiveness analysis based on an epidemiological model.

Setting Analyses undertaken for two regions classified by WHO according to their epidemiological grouping—Afr-E, countries in sub-Saharan Africa with very high adult and high child mortality, and Sear-D, countries in South East Asia with high adult and high child mortality.

Data sources Published studies, costing databases, expert opinion.

Main outcome measures Costs per disability adjusted life year (DALY) averted in 2000 international dollars ($Int).

Results Treatment of new cases of smear-positive tuberculosis in DOTS programmes cost $Int6-8 per DALY averted in Afr-E and $Int7 per DALY averted in Sear-D at coverage levels of 50-95%. In Afr-E, adding treatment of smear-negative and extra-pulmonary cases at a coverage level of 95% cost $Int95 per DALY averted; the addition of DOTS-Plus treatment for multidrug resistant cases cost $Int123. In Sear-D, these costs were $Int52 and $Int226, respectively. The full combination of interventions could reduce prevalence and mortality by over 50% in Sear-D between 1990 and 2010, and by almost 50% between 2000 and 2010 in Afr-E.

Conclusions DOTS treatment of new smear-positive cases is the first priority in tuberculosis control, including in countries with high HIV prevalence. DOTS treatment of smear-negative and extra-pulmonary cases and DOTS-Plus treatment of multidrug resistant cases are also highly cost effective. To achieve the millennium development goal for tuberculosis control, substantial extra investment is needed to increase case finding and implement interventions on a wider scale.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries

Taghreed Adam, Stephen S Lim, Sumi Mehta, Zulfiqar A Bhutta, Helga Fogstad, Matthews Mathai, Jelka Zupan, and Gary L Darmstadt
BMJ 2005 331: 1107. [Abstract] [Full Text] [PDF]

Time to reassess strategies for improving health in developing countries

David B Evans, Taghreed Adam, Tessa Tan-Torres Edejer, Stephen S Lim, Andrew Cassels, Timothy G Evans for the the WHO Choosing Interventions that are Cost Effective (CHOICE) Millennium Development Goals Team
BMJ 2005 331: 1133-1136. [Extract] [Full Text] [PDF]

Methods to assess the costs and health effects of interventions for improving health in developing countries

David B Evans, Tessa Tan-Torres Edejer, Taghreed Adam, Stephen S Lim for the WHO Choosing Interventions that are Cost Effective (CHOICE) Millennium Development Goals Team
BMJ 2005 331: 1137-1140. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Moreira, J., Bisig, B., Muwawenimana, P., Basinga, P., Bisoffi, Z., Haegeman, F., Kishore, P., Van den Ende, J. (2009). Weighing Harm in Therapeutic Decisions of Smear-Negative Pulmonary Tuberculosis. Med Decis Making 29: 380-390 [Abstract]  
• Denny, C. C., Emanuel, E. J. (2008). US Health Aid Beyond PEPFAR: The Mother & Child Campaign. JAMA 300: 2048-2051 [Full text]  
• Dodhia, H., Phillips, K. (2008). Measuring burden of disease in two inner London boroughs using Disability Adjusted Life Years. J Public Health (Oxf) 30: 313-321 [Abstract] [Full text]  
• Dahle, U. R., Eldholm, V., Winje, B. A., Mannsaker, T., Heldal, E. (2007). Impact of Immigration on the Molecular Epidemiology of Mycobacterium tuberculosis in a Low-Incidence Country. Am. J. Respir. Crit. Care Med. 176: 930-935 [Abstract] [Full text]  
• Woo, P. P.S., Kim, J. J., Leung, G. M. (2007). What Is the Most Cost-Effective Population-Based Cancer Screening Program for Chinese Women?. JCO 25: 617-624 [Abstract] [Full text]  
• Sharma, S. K., Mohan, A. (2006). Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control.. Chest 130: 261-272 [Abstract] [Full text]  
• Evans, D. B, Lim, S. S, Adam, T., Edejer, T. T.-T., WHO Choosing Interventions that are Cost Effective, (2005). Evaluation of current strategies and future priorities for improving health in developing countries. BMJ 331: 1457-1461 [Full text]  
• Adam, T., Lim, S. S, Mehta, S., Bhutta, Z. A, Fogstad, H., Mathai, M., Zupan, J., Darmstadt, G. L (2005). Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries. BMJ 331: 1107- [Abstract] [Full text]  
• Evans, D. B, Adam, T., Edejer, T. T.-T., Lim, S. S, Cassels, A., Evans, T. G, for the the WHO Choosing Interventions that are Co, (2005). Time to reassess strategies for improving health in developing countries. BMJ 331: 1133-1136 [Full text]  
• Evans, D. B, Edejer, T. T.-T., Adam, T., Lim, S. S, for the WHO Choosing Interventions that are Cost E, (2005). Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ 331: 1137-1140 [Full text]  

Online poll

Find out more on doc2doc >>